Board Of Directors

 

Daniel Einhorn is a principal in Midwest Capital Fund, a venture capital fund that has invested in PMEDS ’s two roundsof investment in 2006 and 2008, both of which were led by his father Stephen Einhorn. At Capital Midwest, Daniel focuses on new client development, syndicating investment for portfolio life science companies, financial analysis, strategic planning, and market research. His education includes an MBA in finance from the Cox business school at SMU, as well as a BS from Cornell University.

 The fund concentrates on investments where companies have excellent management and technology, are performing an important function, and will address significant markets.  The fund looks for management with successful previous experience; markets that are established and growing; defensible IP positions; and sustainable competitive advantages. The principals of the fund are professionals who have operated in the investment banking, investing, life science and technology industries for many years. They have significant experience in raising money for early-stage companies and sourcing deals. In addition, they have significant experience in assisting management teams prepare viable business plans, evaluate strategic partnerships, and craft lucrative exits.

Capital Midwest Fund recently raised $40 million for a second venture capital fund called Tosa Venture Fund. Hedge fund manager and President of Greenlight Capital, David Einhorn who is the brother of Daniel Einhorn is an investor.

 

 

Joe Fenn, MD – Founder, Chief Operating & Medical Officer

Dr. Fenn is a highly motivated and creative “physician marketer.” He received his medical training from the Christian Medical College, one of India’s premiere medical schools.

Dr. Fenn inherited a rich tradition of Ayurvedic medicine from his great-grandfather and grand-uncles, who have been practicing Ayurvedic medicine for the last 80 years in India.

For the past 16 years, Dr. Fenn has been working in the United States and has held senior executive level positions with Sanofi–Aventis and HealthSTAR Communications(a medical communications and advertising company).

Dr. Fenn brings a solid blend of collective experiences, including medical and pharmaceutical marketing, brand management, pharmaceutical regulatory affairs, strategic thinking, innovation and proven execution ability to help build value and successful therapeutic brands.

Additionally, his years in Pharmaceutical Marketing, Medical Education has offered him the opportunity to develop and nurture strong personal relationship with top medical influencers in the country. In his role as Director of Global Marketing for Sanofi-Aventis, he was part of the team that successfully launched Lantus®, a multi-billon dollar blockbuster diabetes drug.